Skip to main content

Table 2b Characteristics of the clinical practice guidelines examined by the included studies

From: Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries

Author/Year/Reference Scope of the guideline(s) Type of health care recommendation adherence was studied Guidelines studied
Andreano 2017 [17] National (Italian) guideline and European guidelines* Diagnosis and treatment (generic) NICE guideline a; ESMO guideline b
de Roos 2005 [36] National (Dutch) Treatment (treatment of patients with DCIS) Otter 2003c
Ebner, Hancke 2015 [18] National (German) Treatment (generic) S3 guideline d
Ebner 2015 [19] National (German) Treatment (generic) S3 guideline d
Hancke 2010 [37] National (German) and international guidelines* Treatment (generic) 2005 St Gallen consensus e; S3 guideline d
Jacke 2015 [21] National (German) Treatment (generic) S3 guideline d
Mille 2000 [38] Regional (French) Follow-up (post therapeutic follow-up) Centre Régional Léon Bérard guidelines f
Poncet 2009 [39] National and regional (French) guidelines Breast cancer treatment (specific for trastuzumab treatment) French post licensing guidelines (2001), regional clinical guidelines published by the regional oncology care network called “Convergence” in the French Rhone-Alpes area (no additional information provided).
Sacerdote 2013 [40] Regional (Italy) guidelines Treatment (generic) Piedmont Clinical Practice Guideline g
Schwentner 2012 [43] National (German) Treatment (adjuvant) S3 guideline d
Schwentner 2012 [42] National (German) Treatment (generic) S3 guideline d
Schwentner 2013 [41] National (German) Treatment (generic) S3 guideline d
Van de Water 2012 [44] National (Dutch) Treatment (guidelines for breast and axillary surgery, radiotherapy, chemotherapy and endocrine therapy) Dutch guideline h
Van Ewijk 2015 [45] National (German) Treatment (adjuvant treatment) S3 guideline d
Varga 2010 [46] National (German) Treatment (treatment of early-onset breast cancer) S3 guideline d
Wollschlager 2017 [20] National (German) Treatment (guidelines for adjuvant treatment) S3 guideline d
Wockel, Kurzeder et al. 2010 [48] National (German) and international guidelines* Treatment (generic) 2005 St Gallen consensus e; S3 guideline d
Wockel, Varga et al. 2010 [47] National (German) and international guidelines* Treatment (generic) 2005 St Gallen consensus e; S3 guideline d
Wolters 2015 [22] National (German) Treatment (adjuvant treatment) S3 guideline d
Wockel 2014 [30] National (German) Treatment (generic) S3 guideline d
Wimmer 2019 [49] National (German) Treatment (radiotherapy) S3 guideline d
  1. * adherence to recommendations from two different guidelines examined in this study
  2. a, Early and locally advanced breast cancer diagnosis and treatment: full guideline. National Collaborating Centre for Cancer, Cardiff https://www.nice.org.uk/guidance/cg80/resources/early-and-locallyadvanced- breast-cancer-diagnosis-and- reatment-975,682,170,565
  3. b, Senkus E, Kyriakides S, Ohno S et al. (2015) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatmentand follow-up. Ann Oncol 26:v8–v30. doi:https://doi.org/10.1093/annonc/ mdv298
  4. c, Otter R (ed) (2003) Richtlijnen voor diagnostiek en behandeling van premaligne en maligne aandoeningen in de IKN-regio 2003 pp. 338–339. Groningen: IKN; ISBN 90–74,114–25-3
  5. d, Kreienberg K, Kopp I, Lorenz et al. Interdisciplinary S3 Guidelines for the diagnosis and treatment of breast cancer in women. German Cancer Society. 2004
  6. e, Goldhirsch A, Glick JH, Gelber RD et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 1569–1583. 9
  7. f, Centre Régional Léon Bérard, Réseau Oncora: The’saurus ONCORA en Cancérologie. Paris, France, Arnette Blackwell, 1997, p 374
  8. g, Regione Piemonte Assessorato Sanità, Commissione Oncologica Regionale, Centro di Riferimento per l’Epidemiologia e la Prevenzione Oncologica in Piemonte: Tumore della mammella - linee guida clinico organizzative per la
  9. Regione Piemonte. 2002
  10. h, Oncoline. Dutch National Breast Cancer Guidelines. http://www.oncoline.nl/mammacarcinoom